Annual Working Capital
-$6.10 M
-$11.98 M-203.56%
December 1, 2023
Summary
- As of February 7, 2025, NLSP annual working capital is -$6.10 million, with the most recent change of -$11.98 million (-203.56%) on December 1, 2023.
- During the last 3 years, NLSP annual working capital has risen by +$910.70 thousand (+13.00%).
- NLSP annual working capital is now -203.56% below its all-time high of $5.89 million, reached on December 31, 2022.
Performance
NLSP Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
-$6.53 M
-$429.10 K-7.04%
June 1, 2024
Summary
- As of February 7, 2025, NLSP quarterly working capital is -$6.53 million, with the most recent change of -$429.10 thousand (-7.04%) on June 1, 2024.
- Over the past year, NLSP quarterly working capital has dropped by -$4.88 million (-296.16%).
- NLSP quarterly working capital is now -192.58% below its all-time high of $7.05 million, reached on June 30, 2021.
Performance
NLSP Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
NLSP Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -203.6% | -296.2% |
| 3 y3 years | +13.0% | -296.2% |
| 5 y5 years | -162.3% | -296.2% |
NLSP Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -203.6% | at low | -210.8% | at low |
| 5 y | 5-year | -203.6% | +13.0% | -192.6% | +6.9% |
| alltime | all time | -203.6% | +13.0% | -192.6% | +6.9% |
NLS Pharmaceutics AG Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2024 | - | -$6.53 M(+7.0%) |
| Dec 2023 | -$6.10 M(-203.6%) | -$6.10 M(+270.1%) |
| Jun 2023 | - | -$1.65 M(-128.0%) |
| Dec 2022 | $5.89 M(+77.3%) | $5.89 M(-524.0%) |
| Jun 2022 | - | -$1.39 M(-141.8%) |
| Dec 2021 | $3.32 M | $3.32 M(-52.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2021 | - | $7.05 M(-200.6%) |
| Dec 2020 | -$7.01 M(+91.8%) | -$7.01 M(+55.7%) |
| Jun 2020 | - | -$4.50 M(+23.2%) |
| Dec 2019 | -$3.65 M(+57.2%) | -$3.65 M(+128.1%) |
| Jun 2019 | - | -$1.60 M(-31.1%) |
| Dec 2018 | -$2.32 M(-281.1%) | -$2.32 M |
| Dec 2017 | $1.28 M | - |
FAQ
- What is NLS Pharmaceutics AG annual working capital?
- What is the all time high annual working capital for NLS Pharmaceutics AG?
- What is NLS Pharmaceutics AG annual working capital year-on-year change?
- What is NLS Pharmaceutics AG quarterly working capital?
- What is the all time high quarterly working capital for NLS Pharmaceutics AG?
- What is NLS Pharmaceutics AG quarterly working capital year-on-year change?
What is NLS Pharmaceutics AG annual working capital?
The current annual working capital of NLSP is -$6.10 M
What is the all time high annual working capital for NLS Pharmaceutics AG?
NLS Pharmaceutics AG all-time high annual working capital is $5.89 M
What is NLS Pharmaceutics AG annual working capital year-on-year change?
Over the past year, NLSP annual working capital has changed by -$11.98 M (-203.56%)
What is NLS Pharmaceutics AG quarterly working capital?
The current quarterly working capital of NLSP is -$6.53 M
What is the all time high quarterly working capital for NLS Pharmaceutics AG?
NLS Pharmaceutics AG all-time high quarterly working capital is $7.05 M
What is NLS Pharmaceutics AG quarterly working capital year-on-year change?
Over the past year, NLSP quarterly working capital has changed by -$4.88 M (-296.16%)